Hepatitis B virus genome variability and disease progression : the impact of pre-core mutants and HBV genotypesBUTI, Maria; RODRIGUEZ-FRIAS, Francisco; JARDI, Rosendo et al.Journal of clinical virology. 2005, Vol 34, issn 1386-6532, S79-S82, SUP1Conference Paper

Emphysema due to α-antitrypsin deficiency: Familial study of the YBARCELONA variantMIRAVITLLES, Marc; VILA, Sara; JARDI, Rosendo et al.Chest. 2003, Vol 124, Num 1, pp 404-406, issn 0012-3692, 3 p.Article

A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a modelRAMIREZ, Clara; GREGORI, Josep; BUTI, Maria et al.Antiviral research. 2013, Vol 98, Num 2, pp 273-283, issn 0166-3542, 11 p.Article

Analysis of hepatitis B genotype changes in chronic hepatitis B infection : Influence of antiviral therapyJARDI, Rosendo; RODRIGUEZ-FRIAS, Francisco; SCHAPER, Melanie et al.Journal of hepatology. 2008, Vol 49, Num 5, pp 695-701, issn 0168-8278, 7 p.Article

Response-Guided Therapy for Chronic Hepatitis C Virus Infection in Patients Coinfected with HIV : A Pilot TrialVAN DEN EYNDE, Eva; CRESPO, Manuel; VILLAR DEL SAZ, Sara et al.Clinical infectious diseases. 2009, Vol 48, Num 8, pp 1152-1159, issn 1058-4838, 8 p.Article

Usefulness of dried blood samples for quantification and molecular characterization of HBV-DNAJARDI, Rosendo; RODRIGUEZ-FRIAS, Francisco; BUTI, Maria et al.Hepatology (Baltimore, Md.). 2004, Vol 40, Num 1, pp 133-139, issn 0270-9139, 7 p.Article

HBV core region variability: effect of antiviral treatments on main epitopic regionsHOMS, Maria; JARDI, Rosendo; BUTI, Maria et al.Antiviral therapy (London). 2011, Vol 16, Num 1, pp 37-49, issn 1359-6535, 13 p.Article

Sporadic cases of acute autochthonous hepatitis E in SpainBUTI, Maria; CLEMENTE-CASARES, Pilar; JARDI, Rosend et al.Journal of hepatology. 2004, Vol 41, Num 1, pp 126-131, issn 0168-8278, 6 p.Article

Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and DSCHAPER, Melanie; RODRIGUEZ-FRIAS, Francisco; JARDI, Rosendo et al.Journal of hepatology. 2010, Vol 52, Num 5, pp 658-664, issn 0168-8278, 7 p.Article

Use of the Novel INNO-LiPA Line Probe Assay for Detection of Hepatitis B Virus Variants That Confer Resistance to Entecavir TherapyJARDI, Rosendo; RODRIGUEZ-FRIAS, Francisco; TABERNERO, David et al.Journal of clinical microbiology (Print). 2009, Vol 47, Num 2, pp 485-488, issn 0095-1137, 4 p.Article

Adefovir for chronic hepatitis B treatment : identification of virological markers linked to therapy responseRODRIGUEZ-FRIAS, Francisco; JARDI, Rosendo; SCHAPER, Melanie et al.Antiviral therapy (London). 2008, Vol 13, Num 8, pp 991-999, issn 1359-6535, 9 p.Article

Redetection of HBV lamivudine-resistant mutations in a patient under entecavir therapy, who had been treated sequentially with nucleos(T)ide analoguesRODRIGUEZ-FRIAS, Francisco; JARDI, Rosendo; SCHAPER, Melanie et al.Journal of medical virology. 2007, Vol 79, Num 11, pp 1671-1673, issn 0146-6615, 3 p.Article

Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon α-2b plus ribavirinBUTI, Maria; MENDEZ, Claudia; SCHAPER, Melanie et al.Journal of hepatology. 2004, Vol 40, Num 3, pp 527-532, issn 0168-8278, 6 p.Article

Twelve-Week Posttreatment Follow-Up to Predict Sustained Virologic Response for Recurrent Hepatitis C Infection in Liver RecipientsCAMPOS-VARELA, Isabel; CASTELLS, Lluis; IGNACIO ESTEBAN, Juan et al.Transplantation. 2012, Vol 93, Num 4, pp 450-453, issn 0041-1337, 4 p.Article